Experience

Delving into the field of Lymphomas, Clinical Research and Molecular Oncology, Dr. Raúl Córdoba Mascuñano has developed his professional career in many hospitals, becoming Coordinator of the Lymphoma Unit of the Hematology Service of the Hospital Fundación Jiménez Díaz. 

He combines this work with his work as a researcher in various entities, highlighting his participation in clinical trials of lymphoid neoplasms in the START Madrid FJD. In addition, he was vice-president of the Spanish Group of Geriatric Hematology, also forming part of prestigious international committees such as the International Society of Cardio-Oncology, the European Hematology Association (EHA) or the International Society of Geriatric Oncology, among others. 

  • Coordinator of the Lymphoma Unit of the Hematology Service of the Hospital Fundación Jiménez Díaz
  • Specialist in Hematology at the Infanta Sofia, La Paz and La Princesa Hospitals
  • Head of the Lymphoma Line at the Institute of Health Research IIS-FJD 
  • Associate researcher at the Tumorimmunology Laboratory of the Research Institute Hospital La Paz
  • Doctor of Medicine, Universidad Autónoma de Madrid
  • Degree in Medicine from the Universidad Autónoma de Madrid
  • Master's Degree in Molecular Oncology from the Centro Nacional de Investigaciones Oncológicas (Spanish National Cancer Research Center) 
  • Master's Degree in Clinical Research from the Universidad Camilo José Cela 
  • Master's Degree in Clinical Pharmacology and Translational Research from the University of Extremadura
  • International Professional Master's Degree for Leaders in Oncology in Europe, Bocconi University
  • International Certificate in Lymphoma from the Oncology Institute of Italian Switzerland and University of Ulm
  • Member of: 
    • European Hematology Association (EHA) 
    • International Cardio-Oncology Society 
    • American Society of Hematology 
    • SIOG - International Society of Geriatric Oncology 
    • Spanish Society of Hematology and Hemotherapy (SEHH) 
    • The Lancet Haematology, International Advisory Board Member 
Programmes in collaboration with

1 /